Titre : Perception du mouvement

Perception du mouvement : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Systemic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Perception du mouvement : Questions médicales les plus fréquentes", "headline": "Perception du mouvement : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Perception du mouvement : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-21", "dateModified": "2025-04-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Perception du mouvement" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Perception visuelle", "url": "https://questionsmedicales.fr/mesh/D014796", "about": { "@type": "MedicalCondition", "name": "Perception visuelle", "code": { "@type": "MedicalCode", "code": "D014796", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932" } } }, "about": { "@type": "MedicalCondition", "name": "Perception du mouvement", "alternateName": "Motion Perception", "code": { "@type": "MedicalCode", "code": "D009039", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Adam Zaidel", "url": "https://questionsmedicales.fr/author/Adam%20Zaidel", "affiliation": { "@type": "Organization", "name": "Gonda Multidisciplinary Brain Research Center, Bar Ilan University, Ramat Gan, Israel." } }, { "@type": "Person", "name": "Gregory C DeAngelis", "url": "https://questionsmedicales.fr/author/Gregory%20C%20DeAngelis", "affiliation": { "@type": "Organization", "name": "Department of Brain and Cognitive Sciences, University of Rochester, New York, NY 14627, USA." } }, { "@type": "Person", "name": "Yi Jiang", "url": "https://questionsmedicales.fr/author/Yi%20Jiang", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Brain and Cognitive Science, CAS Center for Excellence in Brain Science and Intelligence Technology, Institute of Psychology, Chinese Academy of Sciences, Beijing, China." } }, { "@type": "Person", "name": "Megan J Kobel", "url": "https://questionsmedicales.fr/author/Megan%20J%20Kobel", "affiliation": { "@type": "Organization", "name": "Department of Otolaryngology-Head & Neck Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio." } }, { "@type": "Person", "name": "Andrew R Wagner", "url": "https://questionsmedicales.fr/author/Andrew%20R%20Wagner", "affiliation": { "@type": "Organization", "name": "Department of Otolaryngology-Head & Neck Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Cellular and Molecular Diversity in Scleroderma.", "datePublished": "2022-08-06", "url": "https://questionsmedicales.fr/article/35940960", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.smim.2022.101648" } }, { "@type": "ScholarlyArticle", "name": "Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.", "datePublished": "2024-08-23", "url": "https://questionsmedicales.fr/article/39273131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms25179182" } }, { "@type": "ScholarlyArticle", "name": "Barriers and Facilitators to Physical Activity for People With Scleroderma: A Scleroderma Patient-Centered Intervention Network Cohort Study.", "datePublished": "2022-05-11", "url": "https://questionsmedicales.fr/article/33527717", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/acr.24567" } }, { "@type": "ScholarlyArticle", "name": "Pulmonary Hypertension in Scleroderma- Evaluation and Management.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36163292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.disamonth.2022.101468" } }, { "@type": "ScholarlyArticle", "name": "Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.chest.2022.09.044" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes psychologiques", "item": "https://questionsmedicales.fr/mesh/D011579" }, { "@type": "ListItem", "position": 3, "name": "Processus mentaux", "item": "https://questionsmedicales.fr/mesh/D008606" }, { "@type": "ListItem", "position": 4, "name": "Perception", "item": "https://questionsmedicales.fr/mesh/D010465" }, { "@type": "ListItem", "position": 5, "name": "Perception visuelle", "item": "https://questionsmedicales.fr/mesh/D014796" }, { "@type": "ListItem", "position": 6, "name": "Perception du mouvement", "item": "https://questionsmedicales.fr/mesh/D009039" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Perception du mouvement - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Perception du mouvement", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Perception du mouvement", "description": "Comment évaluer la perception du mouvement ?\nQuels examens sont recommandés ?\nQuels signes indiquent un trouble de la perception ?\nQuand consulter un spécialiste ?\nLa perception du mouvement peut-elle être testée chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D009039?mesh_terms=Scleroderma,+Systemic&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Perception du mouvement", "description": "Quels sont les symptômes d'un trouble de la perception du mouvement ?\nPeut-on ressentir des vertiges ?\nY a-t-il des effets sur l'équilibre ?\nLes illusions de mouvement sont-elles fréquentes ?\nLes troubles de la perception affectent-ils la vision ?", "url": "https://questionsmedicales.fr/mesh/D009039?mesh_terms=Scleroderma,+Systemic&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Perception du mouvement", "description": "Comment prévenir les troubles de la perception ?\nL'exercice régulier aide-t-il ?\nUne alimentation saine est-elle importante ?\nLe stress influence-t-il la perception ?\nDes activités cognitives peuvent-elles aider ?", "url": "https://questionsmedicales.fr/mesh/D009039?mesh_terms=Scleroderma,+Systemic&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Perception du mouvement", "description": "Quels traitements sont disponibles ?\nLes médicaments peuvent-ils aider ?\nLa thérapie physique est-elle efficace ?\nY a-t-il des approches alternatives ?\nLes exercices visuels sont-ils bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D009039?mesh_terms=Scleroderma,+Systemic&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Perception du mouvement", "description": "Quelles complications peuvent survenir ?\nLes troubles de la perception peuvent-ils affecter la vie quotidienne ?\nY a-t-il un risque accru de dépression ?\nLes complications peuvent-elles être évitées ?\nLes troubles de la perception augmentent-ils le risque d'accidents ?", "url": "https://questionsmedicales.fr/mesh/D009039?mesh_terms=Scleroderma,+Systemic&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Perception du mouvement", "description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il la perception du mouvement ?\nLes troubles de l'oreille interne sont-ils un facteur ?\nLe stress chronique est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D009039?mesh_terms=Scleroderma,+Systemic&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la perception du mouvement ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests psychophysiques et des évaluations cliniques sont utilisés." } }, { "@type": "Question", "name": "Quels examens sont recommandés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et l'électroencéphalogramme peuvent aider à diagnostiquer des troubles." } }, { "@type": "Question", "name": "Quels signes indiquent un trouble de la perception ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des difficultés à suivre des objets en mouvement ou des illusions de mouvement." } }, { "@type": "Question", "name": "Quand consulter un spécialiste ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Si des symptômes de désorientation ou de vertige persistent." } }, { "@type": "Question", "name": "La perception du mouvement peut-elle être testée chez les enfants ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests adaptés peuvent évaluer la perception chez les jeunes enfants." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un trouble de la perception du mouvement ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Difficultés à juger la vitesse, la direction ou la distance des objets en mouvement." } }, { "@type": "Question", "name": "Peut-on ressentir des vertiges ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des vertiges peuvent survenir en raison de troubles de la perception." } }, { "@type": "Question", "name": "Y a-t-il des effets sur l'équilibre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la perception du mouvement peuvent affecter l'équilibre." } }, { "@type": "Question", "name": "Les illusions de mouvement sont-elles fréquentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent se produire, surtout dans des conditions de fatigue ou de stress." } }, { "@type": "Question", "name": "Les troubles de la perception affectent-ils la vision ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent entraîner des difficultés visuelles, comme la vision floue." } }, { "@type": "Question", "name": "Comment prévenir les troubles de la perception ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne santé générale et éviter les traumatismes crâniens." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer l'équilibre et la coordination." } }, { "@type": "Question", "name": "Une alimentation saine est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée contribue à la santé neurologique." } }, { "@type": "Question", "name": "Le stress influence-t-il la perception ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les troubles de la perception du mouvement." } }, { "@type": "Question", "name": "Des activités cognitives peuvent-elles aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des jeux de réflexion et des puzzles stimulent la perception et la cognition." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie cognitive et la rééducation vestibulaire sont couramment utilisées." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent traiter les symptômes associés, comme les vertiges." } }, { "@type": "Question", "name": "La thérapie physique est-elle efficace ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut améliorer l'équilibre et la coordination chez les patients." } }, { "@type": "Question", "name": "Y a-t-il des approches alternatives ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la méditation et le yoga peuvent aider à la gestion des symptômes." } }, { "@type": "Question", "name": "Les exercices visuels sont-ils bénéfiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des exercices spécifiques peuvent améliorer la perception du mouvement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des chutes, des accidents et des troubles de l'équilibre peuvent se produire." } }, { "@type": "Question", "name": "Les troubles de la perception peuvent-ils affecter la vie quotidienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent rendre les tâches quotidiennes plus difficiles et dangereuses." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de dépression ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles de la perception peuvent contribuer à des problèmes de santé mentale." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par une réhabilitation précoce." } }, { "@type": "Question", "name": "Les troubles de la perception augmentent-ils le risque d'accidents ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils augmentent le risque d'accidents domestiques et routiers." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque principaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les traumatismes crâniens, les maladies neurologiques et le vieillissement." } }, { "@type": "Question", "name": "L'âge influence-t-il la perception du mouvement ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut altérer la perception et l'équilibre." } }, { "@type": "Question", "name": "Les troubles de l'oreille interne sont-ils un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles vestibulaires affectent la perception du mouvement." } }, { "@type": "Question", "name": "Le stress chronique est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber les troubles de la perception." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles neurologiques peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Barriers and Facilitators to Physical Activity for People With Scleroderma: A Scleroderma Patient-Centered Intervention Network Cohort Study.

To support physical activity among people with systemic sclerosis (SSc [scleroderma]), we sought to determine the prevalence and importance of barriers and the likelihood of using possible facilitator... We invited 1,707 participants from an international SSc cohort to rate the importance of 20 barriers (14 medical, 4 social or personal, 1 lifestyle, and 1 environmental) and the likelihood of using 91... Among 721 respondents, 13 barriers were experienced by ≥25% of participants, including 2 barriers (fatigue and Raynaud's phenomenon) rated "important" or "very important" by ≥50% of participants, 7 ba... Medical-related physical activity barriers were common and considered important. Facilitators considered as most likely to be used involved adapting exercise, taking care of one's body, keeping warm, ...

Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.

Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort.... Do enrichment strategies for progressive ILD impact efficacy, representativeness, and feasibility in patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database?... We applied the inclusion criteria of major recent SSc-ILD trials (Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis [focuSSced], Scleroderma Lung Study II [SLS II... In total, 2,258 patients with SSc-ILD were included: 31.2% of the patients met SENSCIS criteria; 5.8% of the patients met SLS II criteria; 1.6% of the patients met focuSSced criteria, and 67.7% (1,529... The application of enrichment criteria from previous clinical trials showed enrichment for progression with variable success, which led to selected patient populations reducing feasibility of recruitm...

Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).

Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with... Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi... Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0... Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....

Scleroderma autoantibodies in guiding monitoring and treatment decisions.

One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia... There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows... ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...

Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's Syndrome.

The mechanisms of systemic autoimmune diseases (ADs) are still not clearly understood. Understanding the etiology of systemic ADs and identifying new therapeutic targets require a systems science appr...

Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study.

People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe... The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys... Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by... People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...

[Autoimmune and inflammatory pathologies associated with systemic scleroderma: Clinical, serological and prognostic profiles. Bi-centric retrospective series in the PACA region].

Systemic sclerosis (SSc) is a rare auto-immune disease, affecting principally women between 40 and 60 years old. It is caracterised by a cutaneous and visceral fibrosis, an alteration of the microvasc... We have analysed the data of a retrospective and bicentrique cohort, from the internal medicine unit of Hôpital Nord in Marseille and from the internal medicine unit of the Hôpital Sainte-Anne in Toul... The cohort included 151 patients including 134 limited cutaneous SSc. Fifty-two (34.4%) patients presented at least one associated auto-immune or inflammatory disease. The association of two connectiv... SSc is often associated with other autoimmune diseases. This interrelation between associated pathologies and SSc, modifying sometimes the evolution of SSc, enhances the need of a personalized follow-...